T Cell Activation Analysis

Creative Biolabs offers optimal solutions for T-cell activation analysis to meet your project's needs. Customized solutions offer flexibility to meet a range of experimental needs and multiple methods to better meet practical needs. Our analysis facilitates quick identification of T-cell activation status to advance your research.

T-cell Activation

T-cell activation involves complex interactions and requires three signals.

T-cell Activation and identification. Fig.1 T-cell Activation and identification. (Neeve, et al., 2019)

Receiving only signal 1 without co-stimulation results in T cell unresponsiveness or energy, a process known as peripheral tolerance. Once a naive T cell finds the distinct antigen required for activation, an extensive proliferation of antigen-specific T cells is induced. After T-cell activation, a variety of signaling pathways are activated, leading to the expression of functional cell surface markers and the release of cytokines. Activated cells migrate to the periphery where killer T-cells identify infected cells and release toxic substances helper T-cells undergo further differentiation into subtypes.

T Cell Activation Analysis Services

Identification of a reactive T cell. Fig.2 Identification of a reactive T cell. (Kast, et al., 2021)

Partner with Creative Biolabs, and we help you choose the optimal solution for your project. These methods can assess and quantify T-cell activation, allow for a greater understanding of how T cells react to certain stimuli and provide precise information for immune response monitoring. Our scientists can provide precise and consistent handling for repeatable results to reduce variations in assay performance and unreliable data.

As always, we are available for flexible discussions to see how we can collaborate and develop the next generation of cancer therapies. If you are interested in our services, please feel free to contact us to talk about your project.

References

  1. Neeve, S.C.; et al. The role and therapeutic implications of T cells in cancer of the lung. Clinical & translational immunology. 2019, 8(8): e1076.
  2. Kast, F.; et al. Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T-cell therapies. OncoImmunology. 2021, 10(1): 1869389.

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2024 Creative Biolabs. All Rights Reserved.